524506 CORALAB

Coral Laboratories Share Price

₹774.00 -19.3 (-2.43%)

22 Nov, 2024 06:32

SIP TrendupStart SIP in CORALAB

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -8.79%
  • Over 3 Month -5.93%
  • Over 6 Month + 108.99%
  • Over 1 Year + 89.87%
SIP Lightning

Smart Investing Starts Here Start SIP with Coral Laboratories for Steady Growth!

Invest Now

Coral Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Coral Laboratories Financials

Coral Laboratories Technicals

EMA & SMA

Current Price
₹774.00
-19.3 (-2.43%)
pointer
  • stock-down_img
  • Bullish Moving Average 3
  • stock-up_img
  • Bearish Moving Average 13
  • 20 Day
  • ₹834.79
  • 50 Day
  • ₹839.63
  • 100 Day
  • ₹788.73
  • 200 Day
  • ₹676.44

Resistance and Support

776.2 Pivot Speed
  • R3 852.30
  • R2 831.15
  • R1 797.35
  • S1 742.40
  • S2 721.25
  • S3 687.45

What's your outlook on Coral Laboratories?

You can only vote for once

Coral Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-14 Quarterly Results
2024-08-09 Others
2024-07-13 Others
2024-05-23 Audited Results

Coral Laboratories F&O

Coral Laboratories Shareholding Pattern

No data available.

About Coral Laboratories

  • NSE Symbol
  • CORALAB
  • BSE Symbol
  • 524506
  • ISIN
  • INE683E01017

Similar Stocks to Coral Laboratories

Coral Laboratories FAQs

Coral Laboratories share price is ₹774 As on 22 November, 2024 | 06:18

The Market Cap of Coral Laboratories is ₹276.5 Cr As on 22 November, 2024 | 06:18

The P/E ratio of Coral Laboratories is 12 As on 22 November, 2024 | 06:18

The PB ratio of Coral Laboratories is 1.6 As on 22 November, 2024 | 06:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23